FindTrial
Sign In

Application of multi-modal imaging diagnosis in renal tumors and preliminary exploration of artificial intelligence imaging system

Application of multi-modal imaging diagnosis in renal tumors and preliminary exploration of artificial intelligence imaging system

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123442
Enrollment
Unknown
Registered
2026-04-27
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign and malignant renal tumors

Interventions

Gold Standard:Postoperative pathological results
Index test:Parameters of conventional MRI sequence and eDWI, ESWAN and DKI sequence.

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 82 Years

Inclusion criteria

Inclusion criteria: 1. Routine MRI sequence and eDWI, ESWAN and DKI sequence examination of kidney before operation in our hospital; 2. Renal space occupying lesions confirmed by pathology after operation.

Exclusion criteria

Exclusion criteria: 1. The focus is too small to outline ROI;; 2. Breathing motion artifacts make it impossible to measure.

Design outcomes

Primary

MeasureTime frame
Malignant renal disease;Specificity;Accuracy;—

Countries

China

Contacts

Public Contactliuchang

The First Affiliated Hospital of Dalian Medical University

liuchang3@firsthosp-dmu.com+86 4118888888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026